Onconic Therapeutics, Inc. 476060

KRX · South Korea · Health Technology

KRW 15,920.00+570.00 (+3.71%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Onconic Therapeutics, Inc. 476060

KRX · South Korea · Health Technology

KRW 15,920.00+570.00 (+3.71%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-30.63% · 6MFull-screen chart

Open KRW 15,170.00High KRW 16,000.00Low KRW 15,170.00Close KRW 15,920.00Volume 310.77K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: KRW 15,350.00
Day range: KRW 15,170.00 – KRW 16,000.00
52-week range: KRW 8,790.00 – KRW 28,900.00
Volume: 310.77K
Market cap: KRW 697.01B
P/E (TTM): 30.1
Next earnings date: 2026-11-17
Avg. volume (1Y): 1.53M

Performance

1 week

-0.38%

1 month

-11.51%

3 months

+25.95%

6 months

-19.27%

Year to date

-19.84%

1 year

-0.03%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: South Korea
Exchange: KRX
Shares outstanding: 45.41M
Employees: 38
ISIN: KR7476060009
Beta: 0.15

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJul 23, 2026

Bora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO Tablets

MAPLE GROVE, Minn., July 23, 2026--Bora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO Tablets

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.